Impact of the 2008 US Preventive Services Task Force Recommendation to Discontinue Prostate Cancer Screening Among Male Medicare Beneficiaries | Zendy

Joseph S. Ross | Zendy; Rong Wang | Zendy; Jessica B. Long | Zendy; Cary P. Gross | Zendy; Xiaomei Ma | Zendy

Open Access

Impact of the 2008 US Preventive Services Task Force Recommendation to Discontinue Prostate Cancer Screening Among Male Medicare Beneficiaries

Author(s) -

Joseph S. Ross,

Rong Wang,

Jessica B. Long,

Cary P. Gross,

Xiaomei Ma

Publication year - 2012

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinternmed.2012.3726

Subject(s) - task force , prostate cancer , prostate cancer screening , medicine , task (project management) , family medicine , cancer , prostate specific antigen , engineering , political science , public administration , systems engineering

For clinical evidence to have an impact on the health of populations, guideline recommendations must be rapidly and widely disseminated and physicians and other health care professionals must act responsively. Recommendations to discontinue care may be even more challenging. Recently, the US Preventive Services Task Force (USPSTF) recommended that no man receives prostate-specific antigen (PSA)-based screening for prostate cancer.1 While the impact of this recommendation will not be immediately understood in practice, the impact of the USPSTF’s August 2008 recommendation to discontinue PSA-based prostate cancer screening for men 75 years and older may inform expectations.2

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research